About Cyclopharma
Cyclopharma is a company based in Gerzat (France) founded in 2000 was acquired by Curium in April 2018.. Cyclopharma has raised $2.95 million across 1 funding round from investors including Curium Pharma and IXO. Cyclopharma operates in a competitive market with competitors including ImaginAb, AC Immune, APRINOIA, Innovate Biopharma and Progenics, among others.
- Headquarter Gerzat, France
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.95 M (USD)
in 1 rounds
-
Latest Funding Round
$2.95 M (USD), Private Equity Round
May 04, 2017
-
Investors
Curium Pharma
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Curium
(Apr 11, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cyclopharma
Cyclopharma has successfully raised a total of $2.95M through 1 strategic funding round. The most recent funding activity was a Private Equity Round round of $2.95 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Private Equity Round — $2.9M
-
First Round
First Round
(04 May 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2017 | Amount | Private Equity Round - Cyclopharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cyclopharma
Cyclopharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Curium Pharma and IXO. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments in France are managed by IXO.
|
Founded Year | Domain | Location | |
|
Curium Pharma is recognized as a leader in radiopharmaceuticals.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cyclopharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cyclopharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cyclopharma Comparisons
Competitors of Cyclopharma
Cyclopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImaginAb, AC Immune, APRINOIA, Innovate Biopharma and Progenics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| domain | founded_year | HQ Location |
Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases.
|
|
| domain | founded_year | HQ Location |
Diagnostics and therapeutics for neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule drugs and imaging agent for GI disorders
|
|
| domain | founded_year | HQ Location |
Imaging compounds & targeted radiotherapies to detect and treat prostate cancer.
|
|
| domain | founded_year | HQ Location |
Cancer diagnosis devices targeting VPAC1 receptors are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cyclopharma
When was Cyclopharma founded?
Cyclopharma was founded in 2000 and raised its 1st funding round 17 years after it was founded.
Where is Cyclopharma located?
Cyclopharma is headquartered in Gerzat, France. It is registered at Gerzat, Puy-de-dome, France.
Who is the current CEO of Cyclopharma?
Bernard Salin is the current CEO of Cyclopharma.
Is Cyclopharma a funded company?
Cyclopharma is a funded company, having raised a total of $2.95M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $2.95M, raised on May 04, 2017.
What does Cyclopharma do?
Cyclopharma was established in 2000 in Gerzat, France, within the radiopharmaceutical sector. Radiopharmaceuticals for molecular imaging applications are developed and produced by the company. Research and development efforts are concentrated on oncology, cardiology, and neurology. The oncology program SEI810 is advanced to clinical trials, while additional programs remain in early proof-of-concept stages. Operations are centered in Europe, supporting diagnostic and therapeutic advancements.
Who are the top competitors of Cyclopharma?
Who are Cyclopharma's investors?
Cyclopharma has 2 investors. Key investors include Curium Pharma, and IXO.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.